Member Info for Toukankahmoon

At last some realism regarding timescales

CJ62

As you say IF

How many times over the last 5 years have we seen posts like “the next 6 months is going to be sensational with multiple inflexion points “??? And it never is. Each time “it’s going to be different this time” but it never is.

BenH

How long are you going to dine out on my one recent oversight which I admitted and apologised for?

For the avoidance of doubt yes I do now understand that Avacta are in deal discussions that they are not free to disclose.

There happy you sanctimonious pedant?

Bline

Oops thats not going to make you popular with the Avacta fan club👏

Pedrol

My “abuse” is fairly mild and almost always as a retort to some spiteful lies (like yours) or potty mouthed character assassinations.

Why can’t you concentrate on discussing Avacta rather than casting aspersions on fellow Avacta investors??

CJ62

I’ll leave that to Aldebaran

Aldebaran

It’s not just how you see the chances of success. Clearly you have additional information that the world in general hasn’t got that sees you put a higher rate of success on this. BUT it’s also timescale and the money you could have made over past 5 years by investing elsewhere.

Nonetheless 52p is very impressive, I’m envious 👍👏👍👏

Pedrol

I have made it clear that the bulk of my shares are investments not punts. As such they are long term and get reviewed on an annual basis. I do have punts on ABDX, HEMO, STM, EML and others. I do read those BBs and sometimes post if rampers insist on making ludicrous baseless predictions.

But thanks for asking.

Fineprint

Depends on your definition of astronomical. I suspect that we PIs won’t be in line for say £100 per share, though it is nice to dream.

CJ62

Like me, Avacta is not a major portion of his investment portfolio. And like me, he expects to make a profit eventually, meanwhile there are plenty of profits to be made elsewhere.

CJ62

Nice of you to ask. Had an enjoyable weekend but tiring showing my cars at Tatton Park and chewing the cud with a few old mates. One of which was the guy who first put me on to Avacta.

When all else fails out come the insults and the paranoia.

The rampers are certain that BP and IIs have access to more data and more up to date data than us PIs. They certainly have people who are paid to be much more savvy in these matters. With the better PR now and conference presentations, they cannot say that the right people haven’t heard of Avacta. And yet our band of amateur ramping punters know it all and everyone else is thick or being bribed. The naive arrogance of it all.

Give your heads a wobble. The SP is where it is for a reason - there is still significant risk with this investment until the outstanding exceptional clinical results are good enough to trigger deals acceptable to CC.

. . . I wish Big Pharma, institutional investors and the establishment were as clever as NFTs

Lovable

A large proportion of the posters on this BB say that they cannot understand why the SP is so low. Others offer possible reasons and get pilloried in the most offensive personal attacks. What’s not to understand.

So how can you tell who is lying about their investments? Or are they just the ones whose opinions you don’t agree with?

Well at least we can all agree on one thing - no imminent takeover.

My additional point is that I cannot see an imminent license deal because it would have taken away the need for £9M raise.

In other news I am glad that IceCool invests sensibly. My hope is that the rest of you aren’t swayed by the relentless baseless ramping on here and likewise have Avacta as minor portion of your whole investment portfolio.

PS. IceCool- stay out the pub😬

IceCool

It’s hard to take anything you post seriously when you come up with something dumb like that.

We’ve just issued 13M shares at 70p to raise £9M. What sort of dilution would it have caused if we had to raise £9M at 20p🤡

Not worried about saving you all. But just trying to prevent this BB being the Avacta fan club and causing naivety punters to lose money.

Hopefully they have memories and half a brain and can see than hardly any of the unfounded hyped predictions have ever come true.

Personally I’d rather Avacta had delivered decent clinical trial results resulting in a good license deal for AVA6000 as expected.

Pedrol

Desperation because of what?

I have merely stated that if the clinical trial results we were told to expect by June had been good enough there would be an imminent deal. And we wouldn’t need this £9M raise.